Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Smart industry
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Ping An Healthcare and Technology Company Limited
Keypoint Intelligence
Recon Technology, Ltd